Project BITE: Binge Intervention Target Effectiveness
Status: | Completed |
---|---|
Conditions: | Psychiatric |
Therapuetic Areas: | Psychiatry / Psychology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 8/17/2018 |
Start Date: | October 6, 2016 |
End Date: | February 15, 2018 |
An Investigation of Appetitive Cognitive Control: Impact on Treat Outcomes for Binge Eating
The primary aim of this study is to determine how inhibitory neurobiological and
neurocognitive processes relate to binge eating treatment outcome.
neurocognitive processes relate to binge eating treatment outcome.
Binge eating disorder (BED) is characterized by reoccurring binge eating episodes that
consist of eating a subjectively or objectively large amount of food over a period of time
accompanied by a sense of loss control over eating, in the absence of recurrent compensatory
behaviors (e.g., purging). Cognitive behavioral therapy (CBT) is the current gold-standard
treatment for reducing binge eating episodes in BED patients. The first-line of recommended
CBT treatment is a self-guided intervention called CBT-Guided Self-Help (CBT-GSH). However,
for a substantial minority of patients, CBT-GSH fails to reduce binge episodes after
treatment. Preliminary findings of the literature suggests that individuals with BED possess
deficits in inhibitory control as it relates to food-stimuli. We are studying how inhibitory
neurobiological and neurocognitive processes relate to binge eating treatment outcome.
This study involves a brief phone screen and research assessment (approximately 5 hours) to
determine eligibility. Eligible participants will receive CBT-GSH, which will include a
one-hour clinical intake followed by 6 therapy sessions (approximately 30 minutes each).
Participants will also complete research assessments at mid-treatment, post-treatment, and 3
month follow-up intervals. Research assessments include a battery of questionnaires,
computerized tasks, interviews, and a task using functional Near Infrared Spectroscopy (fNIR)
imaging.
consist of eating a subjectively or objectively large amount of food over a period of time
accompanied by a sense of loss control over eating, in the absence of recurrent compensatory
behaviors (e.g., purging). Cognitive behavioral therapy (CBT) is the current gold-standard
treatment for reducing binge eating episodes in BED patients. The first-line of recommended
CBT treatment is a self-guided intervention called CBT-Guided Self-Help (CBT-GSH). However,
for a substantial minority of patients, CBT-GSH fails to reduce binge episodes after
treatment. Preliminary findings of the literature suggests that individuals with BED possess
deficits in inhibitory control as it relates to food-stimuli. We are studying how inhibitory
neurobiological and neurocognitive processes relate to binge eating treatment outcome.
This study involves a brief phone screen and research assessment (approximately 5 hours) to
determine eligibility. Eligible participants will receive CBT-GSH, which will include a
one-hour clinical intake followed by 6 therapy sessions (approximately 30 minutes each).
Participants will also complete research assessments at mid-treatment, post-treatment, and 3
month follow-up intervals. Research assessments include a battery of questionnaires,
computerized tasks, interviews, and a task using functional Near Infrared Spectroscopy (fNIR)
imaging.
Inclusion Criteria:
- Speak, write, and understand English
- Body Mass Index (BMI) of 30 kg/m2 or greater
- Experience objectively or subjectively large binge eating episodes once per week or
more for the past three months
- If applicable, have stable psychiatric medication for the past three months
- For the optional ecological momentary assessment, participants must own a smartphone
compatible with PACO mobile application
Exclusion Criteria:
- Currently engage (in past three months) in any regular compensatory behaviors (e.g.,
self-induced vomiting, laxative/diuretic use)
- Acute suicide risk
- Are currently receiving psychological treatment for binge eating
- Are currently receiving weight loss treatment
- Co-morbid clinically significant psychological disorder that would require attention
beyond the study treatment (e.g., psychotic disorder, substance dependence)
- Diagnosis of intellectual disability or autism spectrum disorder
- History of neurological condition or traumatic brain injury
- Current pregnancy
- History of bariatric surgery
- Are currently using a stimulant medication
We found this trial at
1
site
Click here to add this to my saved trials